Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 169 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

 		Myeloid Diseases Phase1 France
Germany
Hong Kong
Italy
Singapore
Spain
United States
View All
 NCT05552469

Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease

 		Steroid-refractory Acute Graft Versus Host Disease Phase4 China NCT06462469

A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

 		Breast Cancer Phase1, Phase2 Australia
Canada
China
France
Germany
Italy
Korea, Republic of
Portugal
Singapore
Spain
United States
View All
 NCT06247995

Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study

 		Multiple Sclerosis Switzerland NCT05285904

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

 		Aortic Stenosis Phase2 Austria
Belgium
Canada
Czechia
Denmark
France
Germany
Israel
Italy
Netherlands
Portugal
Spain
Switzerland
United Kingdom
United States
View All
 NCT05646381

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

 		Relapsing Multiple Sclerosis Phase3 Argentina
Brazil
Bulgaria
Canada
China
Croatia
Estonia
France
Greece
India
Italy
Japan
Mexico
Poland
Portugal
Puerto Rico
Romania
Slovakia
Slovenia
South Africa
Spain
Sweden
Turkey
United Kingdom
United States
View All
 NCT05156281

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

 		Prostate Cancer Phase2 Japan NCT05114746

A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China

 		Chronic Spontaneous Urticaria China NCT06053801

Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma

 		Newly Diagnosed and Recurrent Glioblastoma Phase1 France
Germany
Israel
Italy
Portugal
Spain
United States
View All
 NCT05739942

Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer

 		Metastatic Castration Resistant Prostate Cancer Germany NCT06517719